Top Markets
#1 Glidr Glidr +51.75%
#2 DOVU DOVU +48.15%
#3 Velvet Velvet +34.29%
#4 Black Phoenix Black Phoenix +34.09%
#5 Cross Cross +30.50%
#6 Akedo Akedo +28.62%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.95%
#8 OVERTAKE OVERTAKE +15.82%
#9 QANplatform QANplatform +14.38%
#10 Perle Perle +12.91%
Coin of the day
Glidr Glidr
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
ZyVersa Therapeutics, Inc. ZyVersa Therapeutics, Inc.

ZyVersa Therapeutics, Inc.

ZVSA
Classifica tra le azioni #38793
ZyVersa Therapeutics, Inc. is a biopharmaceutical firm in its clinical... ZyVersa Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, dedicated to advancing and commercializing therapies for renal (kidney) and inflammatory disorders. The company's pipeline prominently features VAR 200, a cholesterol efflux modulator aimed at addressing kidney diseases such as focal segmental glomerulosclerosis, Alport syndrome, and diabetic kidney disease. Furthermore, ZyVersa is advancing IC 100, a pioneering inflammasome ASC inhibitor positioned to tackle a wide array of inflammatory conditions. The company maintains its corporate headquarters in Weston, Florida.
Prezzo delle azioni
$0.099
Capitalizzazione di mercato
$801.50K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-34.44%
Paese
US
Scambia ZyVersa Therapeutics, Inc. (ZVSA)

Categoria

Healthcare
Rapporto P/B per ZyVersa Therapeutics, Inc. (ZVSA)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di ZyVersa Therapeutics, Inc., il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per ZyVersa Therapeutics, Inc. da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE